194 related articles for article (PubMed ID: 34800526)
21. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
22. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
23. The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.
Molnar A; Yusenko MV; Kovacs G; Banyai D
Anticancer Res; 2020 Dec; 40(12):6863-6867. PubMed ID: 33288578
[TBL] [Abstract][Full Text] [Related]
24. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and Immunohistochemical Characterization of Sarcomatoid Chromophobe Renal Cell Carcinoma: An Analysis of 22 Cases.
Whaley RD; Cheng L
Am J Surg Pathol; 2022 Sep; 46(9):1171-1179. PubMed ID: 35687360
[TBL] [Abstract][Full Text] [Related]
26. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
27. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
28. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
Zhou J; Yang X; Zhou L; Zhang P; Wang C
Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
[TBL] [Abstract][Full Text] [Related]
29. [Pigmented microcystic chromophobe renal cell carcinoma: a clinicopathologic analysis of five cases].
Zhao M; Wang YB; Zhang Q; Jin L; Yang ZR; Zhang X; Ru GQ; Zhang DH; He XL
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):926-930. PubMed ID: 30522173
[No Abstract] [Full Text] [Related]
30. Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous: Clinicopathologic and Molecular Study.
Tjota M; Chen H; Parilla M; Wanjari P; Segal J; Antic T
Am J Surg Pathol; 2020 Jul; 44(7):943-954. PubMed ID: 32091432
[TBL] [Abstract][Full Text] [Related]
31. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
32. Atypical Renal Cysts: A Morphologic, Immunohistochemical, and Molecular Study.
Matoso A; Chen YB; Rao V; Wang L; Cheng L; Epstein JI
Am J Surg Pathol; 2016 Feb; 40(2):202-11. PubMed ID: 26574846
[TBL] [Abstract][Full Text] [Related]
33. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
35. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.
Abbosh P; Sundararajan S; Millis SZ; Hauben A; Reddy S; Geynisman DM; Uzzo R
Eur Urol Focus; 2018 Dec; 4(6):969-971. PubMed ID: 28753842
[TBL] [Abstract][Full Text] [Related]
36. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).
Yang Y; Vocke CD; Ricketts CJ; Wei D; Padilla-Nash HM; Lang M; Sourbier C; Killian JK; Boyle SL; Worrell R; Meltzer PS; Ried T; Merino MJ; Metwalli AR; Linehan WM
Genes Chromosomes Cancer; 2017 Oct; 56(10):719-729. PubMed ID: 28736828
[TBL] [Abstract][Full Text] [Related]
37. Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
Chan E; Stohr BA; Butler RS; Cox RM; Myles JL; Nguyen JK; Przybycin CG; Reynolds JP; Williamson SR; McKenney JK
Am J Surg Pathol; 2022 Mar; 46(3):392-403. PubMed ID: 34881751
[TBL] [Abstract][Full Text] [Related]
38. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
39. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
40. Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma.
Kapur P; Zhong H; Le D; Mukhopadhyay R; Miyata J; Carrillo D; Rakheja D; Rajaram S; Durinck S; Modrusan Z; Brugarolas J
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38775158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]